This document provides an overview of the U-Vend company, which operates in several business segments including novelty ice cream, automated retail through vending machines, digital advertising, fantasy sports, and sports collectibles. It describes U-Vend's growth in revenue and points of sale over the past year. The document also outlines opportunities in each of U-Vend's business segments and strategies for expanding into new markets in North America by identifying popular sports, attractions and interests in different regions. It presents financial summaries showing increased revenue and gross profit for U-Vend over the past year.
Giggles n' Hugs is the first and only restaurant that brings together high-end, organic food with play elements and entertainment for children. GIGL offers an upscale, family-friendly atmosphere with a play area filled with climbers, life size pirate ships and castles dedicated to children ages 10 and younger. The restaurant has a high-quality menu made from fresh, organic foods that are enjoyed by both children and adults, along with nightly entertainment such as magic shows, concerts, puppet shows, face painting, and arts and crafts. GIGL was rated among the best family and kid-friendly restaurants by City Search and Nickelodeon, and has been featured in numerous major news programs and publications, including ABC news, FOX News, The Talk on CBS, TV Guide Channel, Extra, Access Hollywood, Entertainment Tonight, Businessweek, People Magazine, US Magazine, and others. The Company currently has 3 company owned restaurant locations and plans to have 12 company owned restaurant locations by 2017.
iSalesStrategy.com - International Trading, Marketing, Sales & DistributionThe CME Agency
iSales Strategy is a knowledge-based company composed of FMCG (Fast Moving Consumer Goods) experts in the field of sales and marketing from different markets around the world. We distribute products for Fortune 500's and global brands in the ASEAN, Asian, Middle East, North & South American regions.
Giggles n' Hugs is the first and only restaurant that brings together high-end, organic food with play elements and entertainment for children. GIGL offers an upscale, family-friendly atmosphere with a play area filled with climbers, life size pirate ships and castles dedicated to children ages 10 and younger. The restaurant has a high-quality menu made from fresh, organic foods that are enjoyed by both children and adults, along with nightly entertainment such as magic shows, concerts, puppet shows, face painting, and arts and crafts. GIGL was rated among the best family and kid-friendly restaurants by City Search and Nickelodeon, and has been featured in numerous major news programs and publications, including ABC news, FOX News, The Talk on CBS, TV Guide Channel, Extra, Access Hollywood, Entertainment Tonight, Businessweek, People Magazine, US Magazine, and others. The Company currently has 3 company owned restaurant locations and plans to have 12 company owned restaurant locations by 2017.
iSalesStrategy.com - International Trading, Marketing, Sales & DistributionThe CME Agency
iSales Strategy is a knowledge-based company composed of FMCG (Fast Moving Consumer Goods) experts in the field of sales and marketing from different markets around the world. We distribute products for Fortune 500's and global brands in the ASEAN, Asian, Middle East, North & South American regions.
To scale and grow your digital marketing agency, you need to offer more to your clients. Easy right? Not so fast.
Do you spend more money and time hiring and training staff to support new services, or do you risk quality of work by bringing in independent contractors?
Check out these webinar slides to learn clever, time-saving ways to expand your agency offerings and increase profits. You’ll also learn how to:
• Fill gaps that are hurting your revenue.
• Gain and retain quality clients.
• Use a secret swiss army knife of targeting tools not seen anywhere else.
Do you have a strategy in place to emerge from COVID-19 ahead of your competition? In this webinar, financial, data, and marketing experts will break down the three most important parts of your income statement to focus on to successfully navigate the current COVID-19 situation and accompanying economic consequences.
We will share examples and case studies of how businesses have catapulted themselves ahead of their competitors by focusing on specific activities during economic downturns, such as increasing the ROI on marketing efforts and implementing cost cutting measures (improving customer retention and reducing process inefficiencies).
We can only speculate how the economy will recover following the pandemic. There is the possibility of a “V” rebound – sharp downturn followed by sharp upturn, but that is becoming less and less likely each day. Businesses need to prepare a “U” or an “L” or even a Nike-style “swoosh” type recover that could take up to 24 months.
What we do know is that Covid19 marks an inflection point: The world after it is unlikely to resemble the one before it. CEO’s need to remake their organizations to cope with the “new normal”.
This presentation gives insight into the marketing strategy of P&G.
It deals with various marketing capabilities which the P&G is exploring to continue to be the world leader in consumer goods market.
This document brings together a set
of latest data points and publicly
available information relevant for
Retail & Consumer good. We are
very excited to share this content and
believe that readers will benefit from
this periodic publication immensely
2011 ANNUAL REPORTInnovating for Everyday Life$82..docxeugeniadean34240
2011 ANNUAL REPORT
Innovating for Everyday Life
$82.6
$78.9
$76.7
$79.3
$72.4
11
09
08
07
10
Net Sales ($ billions)
30%
4%
19%
9%
14%
24%
By business segment
Beauty
Grooming
Health Care
Snacks & Pet Care
Fabric Care & Home Care
Baby Care & Family Care
2011 Net Sales
9%
14%
16%
41%
20%
By geographic region
North America
Western Europe
Central & Eastern Europe,
Middle East & Africa
Latin America
Asia
35% 65%
By market maturity
Developed
Developing
$13.2
$16.1
$14.9
$15.0
$13.4
11
09
08
07
10
Operating Cash Flow ($ billions)
$3.93
$4.11
$4.26
$3.64
$3.04
11
09
08
07
10
Diluted Net Earnings (per common share)
Contents
Letter to Shareholders................................. 1
Leadership Brands.......................................9
Innovating for Everyday Life...................... 14
Gillette Guard ........................................ 16
Brazil...................................................... 18
Crest 3D White ......................................20
Gain Dishwashing Liquid ........................22
Head & Shoulders ..................................24
Old Spice ...............................................26
Disaster Relief ...........................................28
Financial Contents ....................................29
Global Leadership Council......................... 75
Board of Directors..................................... 75
Financial Summary.................................... 76
Company and Shareholder Information..... 78
Financial Highlights (unaudited)
Amounts in millions, except per share amounts 2011 2010 2009 2008 2007
Net Sales $82,559 $78,938 $76,694 $79,257 $72,441
Operating Income 15,818 16,021 15,374 15,979 14,485
Net Earnings 11,797 12,736 13,436 12,075 10,340
Net Earnings Margin from Continuing Operations 14.3% 13.9% 13.9% 14.2% 13.3%
Diluted Net Earnings per Common Share from Continuing Operations $3.93 $3.53 $3.39 $3.40 $2.84
Diluted Net Earnings Per Common Share 3.93 4.11 4.26 3.64 3.04
Dividends Per Common Share 1.97 1.80 1.64 1.45 1.28
Dear Shareholders,
Last year, I described P&G’s Purpose-inspired Growth Strategy, which is to
touch and improve more consumers’ lives in more parts of the world more
completely. I told you that we intend to deliver total shareholder return
that consistently ranks P&G among the top third of our peers — the best-
performing consumer products companies in the world. To do this, we
must deliver the Company’s long-term annual growth goals, which are to:
Grow organic sales 1% to 2% faster than
market growth in the categories and countries
where we compete
Deliver core earnings per share (core EPS) growth
of high single to low double digits
Generate free cash flow productivity of
90% or greater
Robert A. McDonald
Chairman of the Board, President and
Chief Executive Officer
We made meaningful progress toward these long-term goals
for fiscal 2011, despite significant external chal.
Based in Ann Arbor, Michigan, Zomedica is a veterinary health company creating diagnostic and therapeutic products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. With modest cash burn and a strong balance sheet, including $142.4 million cash and cash equivalents as of June 30, 2023, Zomedica is well-positioned to fund both organic growth and acquisitions.
Dócola is a social good organization with the only free care communication platform that consolidates thousands of free and low-cost patient education resources from the leading nonprofit, government, and commercial organizations in one marketplace. Plus, you can easily create and upload your own resources.
INNO HOLDINGS INC. is an innovative building-technology company with a mission to transform the construction industry with our proprietary cold-formed steel- framing technology and other building innovations
Everything Blockchain builds platforms of trust for the modern enterprise and is on a mission to ensure every organization has access to the tools and platforms that enable them to manage, store, and protect data without the cost and complexity that holds them back today. The Company’s patented advances in engineering deliver the essential elements needed for real-world business use: speed, security, and efficiency. Everything Blockchain’s current business lines include: EB Advise, Build DB and EB Control.
ASP Isotope is an isotope enrichment company utilizing technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses. Many of these elements are unsuitable for enrichment using traditional methods such as centrifuges. The Company’s initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries.
MDNA Life Sciences is a pioneer in the science of mitochondrial DNA. It’s our mission to create an extensive portfolio of proprietary tests that dramatically improve diagnosis, treatment, prognosis and monitoring. Putting an end to the unnecessary surgical procedures, pain and uncertainty that affect patients across the world.
Digital Ally, Inc. is a diversified holding company with operations in video solution technology, human and animal health protection products, healthcare revenue cycle management, ticket brokering and marketing, and event production. The Company pursues an acquisition strategy that targets organizations with positive earnings, strong growth potential, innovation, and operational synergies. To maximize long-term shareholder value, Digital Ally intends to spin-off its ticketing and entertainment business lines into a separate public company in 2023. The spin-off will create two optimized, tech-driven public companies with strong growth opportunities and operating metrics.
Lantern Pharma is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Our proprietary AI and machine learning (ML) platform, RADR®, leverages over 25 billion oncology-focused data points and a library of 200+ advanced ML algorithms to help solve billion-dollar, real-world problems in oncology drug development. By harnessing the power of AI and with input from world-class scientific advisors and collaborators, we have accelerated the development of our growing pipeline of therapies including eleven cancer indications and an antibody-drug conjugate (ADC) program. On average, our newly developed drug programs have been advanced from initial AI insights to first-in-human clinical trials in 2-3 years and at approximately $1.0-2.0 million per program.
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. The Company’s product lines focus on low waste and ultra-low waste syringe technologies that incorporate both passive and active safety features. These features protect front line healthcare workers from life-threatening needle stick injuries and protect the public from needle re-use. Sharps Technology has extensive expertise in specialized prefilled syringe systems and is on track to launch this new product line in Q4 2023. The Company has a manufacturing facility in Hungary and has partnered with Nephron Pharmaceuticals to expand its manufacturing capacity in the US.
Aditxt is a global innovation company focused on discovering and developing precision medicine innovations and deploying them into high-performing businesses. Aditxt’s diverse innovation portfolio includes: Adimune™, Inc., developing and designing a new class of therapeutics for retraining the immune system to address organ rejection, autoimmunity, and allergies; Adivir™, Inc., focused on identifying, developing and commercializing new ways to treat infectious diseases; and Pearsanta™, Inc., offering convenient, rapid, personalized, and high-quality lab testing —anytime and anywhere at its CLIA certified and CAP accredited clinical laboratory based in Richmond, VA.
1847 Holdings LLC, a publicly traded diversified acquisition holding company, was founded by Ellery W. Roberts, a former partner of Parallel Investment Partners, Saunders Karp & Megrue and Principal of Lazard Freres Strategic Realty Investors. EFSH's investment thesis is that capital market inefficiencies have left the founders and/or stakeholders of many small business enterprises and lower-middle market businesses with limited exit options, despite the intrinsic value of their business. Given this dynamic, EFSH can consistently acquire "solid" businesses for reasonable multiples of cash flow and then deploy resources to strengthen the infrastructure and systems to improve operations. These improvements may lead to a sale or IPO of an operating subsidiary at considerably higher valuations than the purchase price (as successfully demonstrated with the mid-2020 IPO of 1847 Goedeker on the NYSE American) and/or alternatively, an operating subsidiary may be held in perpetuity and contribute to EFSH's ability to pay regular and special dividends to shareholders.
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. The Company’s product lines focus on low waste and ultra-low waste syringe technologies that incorporate both passive and active safety features. These features protect front line healthcare workers from life-threatening needle stick injuries and protect the public from needle re-use. Sharps Technology has extensive expertise in specialized prefilled syringe systems and is on track to launch this new product line in Q4 2023. The Company has a manufacturing facility in Hungary and has partnered with Nephron Pharmaceuticals to expand its manufacturing capacity in the US.
SPI Energy is a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions that was founded in 2006 in Roseville, California and is headquartered in McClellan Park, California. The Company has three core divisions: SolarJuice which has solar wholesale distribution, as well as residential solar and roofing installation and solar module manufacturing (Solar4America & SEM Wafertech), SPI Solar and Orange Power which operates a commercial & utility solar division, and the EdisonFuture/Phoenix Motor EV division. SolarJuice is the leader in renewable energy system solutions for residential and small commercial markets and has extensive operations in the Asia Pacific and North America markets. The SPI Solar commercial & utility solar division provides a full spectrum of EPC services to third party project developers, and develops, owns and operates solar projects that sell electricity to the grid in multiple regions, including the U.S., U.K., and Europe. Phoenix Motor is a leader in medium-duty commercial electric vehicles, and is developing EV charger solutions, electric pickup trucks, electric forklifts, and other EV products. SPI maintains global operations in North America, Australia, Asia and Europe and is also targeting strategic investment opportunities in fast growing green energy industries such as battery storage, charging stations, and other EVs which leverage the Company's expertise and substantial solar cash flow.
BullFrog AI is a technology enabled drug development company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University and J. Craig Venter Institute, BullFrog AI is at the forefront of AI-driven drug development. Using its proprietary bfLEAP™ artificial intelligence platform, BullFrog AI aims to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. BullFrog AI is deploying bfLEAP™ for use at several critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics, and impacting the lives of countless patients that may have otherwise not received the therapies they need.
BullFrog AI is a technology enabled drug development company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University and J. Craig Venter Institute, BullFrog AI is at the forefront of AI-driven drug development. Using its proprietary bfLEAP™ artificial intelligence platform, BullFrog AI aims to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. BullFrog AI is deploying bfLEAP™ for use at several critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics, and impacting the lives of countless patients that may have otherwise not received the therapies they need.
BioVie is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. The Company is developing NE3107 for Alzheimer’s (AD) and Parkinson’s (PD) and BIV201 for refractory ascites and HRS-AKI.
Lantern Pharma is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Our proprietary AI and machine learning (ML) platform, RADR®, leverages over 25 billion oncology-focused data points and a library of 200+ advanced ML algorithms to help solve billion-dollar, real-world problems in oncology drug development. By harnessing the power of AI and with input from world-class scientific advisors and collaborators, we have accelerated the development of our growing pipeline of therapies including eleven cancer indications and an antibody-drug conjugate (ADC) program. On average, our newly developed drug programs have been advanced from initial AI insights to first-in-human clinical trials in 2-3 years and at approximately $1.0-2.0 million per program.
Genetic Technologies is a diversified molecular diagnostics company. A global leader in genomics-based tests in health, wellness and serious disease through its geneType and EasyDNA brands. GENE offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that has been developed over the past decade and integrates clinical and genetic risk to deliver actionable outcomes to physicians and individuals. Leading the world in risk prediction in oncology, cardiovascular and metabolic diseases, Genetic Technologies continues to develop risk assessment products.
Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wines by the glass, SALT naturally flavored tequilas, Pulpoloco Sangria, and TapouT performance hydration and recovery drinks and TapouT Cognitive Energy Drink. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution.
Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wines by the glass, SALT naturally flavored tequilas, Pulpoloco Sangria, and TapouT performance hydration and recovery drinks and TapouT Cognitive Energy Drink. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution.
3. Forward-Looking Statements
This presentation may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended,
and Section 21E of the Securities Exchange Act of 1934. We have based these forward-looking statements on our current expectations
and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and
assumptions about us and our affiliate companies, that may cause our actual results, levels of activity, performance or achievements to
be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-
looking statements.
This presentation is supplied for informational purposes only and does not constitute (1) an offer to sell, or solicitation of an offer to buy,
and securities of U-Vend, Inc. or (2) a promise or representation that any such offer will be made to the recipient or any other party. This
presentation contains confidential information regarding U-Vend, Inc.
4. 50
%
What We Do
U-Vend’s diversified, multi-channel revenue base includes the following
business segments:
Professional Sports-Themed Brands
‐ Currently the Official Ice Cream of Major League Baseball, others pending
‐ Marrying fantasy sports phenomenon with consumer product sales and sports collectibles
Wholesale Distributor for Mini Melts (novelty ice cream product)
‐ Current points-of-sale over 145, currently focus on Southern California & Las Vegas markets
Digital Advertising Solutions Provider
‐ Wireless Samsung digital software partnership in place 2015
‐ Placing wireless digital at all points-of-sale provides additional ad revenue
6. 50
%
David Graber
Chief Executive Officer
Currently CEO of U-Vend, Inc. and Managing
Principal of Cobrador Capital Advisors, an
investment firm focused on consumer sector.
Previously was Managing Director, Investment
Banking at New Century Partners and National
Securities Corporation.
Acted as CEO of OKC Corporation, a
manufacturer and retailer in home improvement
industry, oversaw national rollout with Home
Depot, created strategic partnerships with major
U.S. homebuilders.
Was Sr. VP and Director with Donaldson, Lufkin &
Jenrette, as well as Credit Suisse First Boston.
Holds dual MBA’s from Columbia University (NYC)
and London Business School (UK). Obtained BA at
Tulane University (1994)
7. 50
%
Mark Chapman
President, U-Vend America, Inc.
Began career in Marketing and Sales with General
Foods Corporation.
Director of Marketing for Dr. Pepper
VP of The Mauna Loa Macadamia Nut Company, took
revenue from $4.5mm to $41mm in 2.5 years.
From 1983-1985, oversaw revenue growth from
$28mm to $87mm as Director of Sales and Marketing
at Malt-O-Meal.
Zone Director in the Specialty Foods Division of
Ralston Purina in St Louis, MO.
Founder and CEO of United Sales Inc., of which he
grew over 10 years and sold to Fleming, Inc.
C-Level Executive positions in the Consumer Products
industry as a business owner and consultant.
BA in Marketing and Psychology, Masters in
Psychology from Richmond University in London, UK.
8. 50
%
Michael Crone
Executive Vice President of Sales
Veteran sales executive of the ice cream industry with
over 40 years of consumer sales and strategic
planning with numerous multi-billion consumer
products companies.
As Senior Vice President of Sales at Wells Dairy for
over 10 years, increased sales over 53% to $1.2
Billion.
In his 5 years at Nestle Ice Cream Company,
increased return on distribution sales 250% through
acquisitions, new businesses, and re-engineering of
operations.
Spent over 8 years at Häagen-Dazs Ice Cream where
he increased sales from $325 Million to over $700
Million.
Holds a degree in Business Management from
Stephen F. Austin University.
9. 50
%
U-Vend Advisory Board
GREG HOGARTH - Greg is currently the owner and operator of the Ontario, Canada-based QSR Group Inc. Mr. Hogarth has grown the QSR Group
from one single Tim Horton’s store in 1986 to 26 Tim Horton’s and Wendy’s restaurants today with combined sales in excess of $50 million and over
1,400 full and part-time employees.
MARCEL DIONNE - Marcel is a naturally gifted goal scorer and playmaker, center Marcel Dionne was one of the most productive offensive
performers in National Hockey League history. Marcel played 18 seasons in the NHL for the Detroit Red Wings, Los Angeles Kings and New York
Rangers and was inducted into the Hockey Hall of Fame in 1992. Marcel retired with 731 goals and 1,771 points.
JAMES BUTTS - James is the Founder and Director of Operation of GPS Distribution Inc., a privately held firm with revenues in excess of $10
million that specializes in distribution of newspapers to retail outlets, home delivery and also includes in excess of 250 vending machine locations
within the Southern Ontario, Canada marketplace. Mr. Butts has over 30 years’ experience and possesses a strong knowledge of logistics,
operations, finance, and cost-savings strategies.
RANDY J. GILLEN - Randy was a partner in the St. Catharines, Ontario law firm Chown, Cairns from 1980 until he retired from the practice of law in
1993. His expertise was concentrated in business and commercial matters, in particular, the negotiation and preparation of licensing and distribution
agreements. Randy developed a licensing program that included arrangements with The Walt Disney Company, Coca-Cola Ltd., Hasbro Inc.,
Cunard, The Random House Group and other well-known entities.
11. ▪ Southern California and Las Vegas
expansion underway
▪ 145 vending units in place, over 125
locations
▪ $1,089,865 gross revenue nine-month
period ended September 30, 2016
▪ Opportunity to expand new US markets
▪ Differentiated product
▪ High gross margin
▪ Only available at retail
▪ Destination purchase/traffic driver
Mini Melts
12. U-Vend offers a broad range of products and services, spanning multiple market segments
Novelty Ice Cream
Our ice cream products serve as a
delivery system for all of the other
U-Vend Products
Automated Retail
Available in many locations;
C-Stores, Wal-Mart, Grocery
Stores, etc.
Digital Marketing
Available through the latest in
touchscreen technology, as well as
through more traditional outlets;
cellphones, tablets, computers.
13. U-Vend offers a broad range of products and services, spanning multiple market segments
Fantasy Sports
As of 2015, nearly 60 MILLION
people in the US and Canada play
fantasy sports
Sports Collectibles
Our novelty ice cream come with
collectibles that are then used to
participate with our fantasy
marketplace
14. Our Opportunities
Across ALL Categories
1. Novelty Ice Cream
2. Automated Retail
3. Digital Advertising
4. Fantasy Sports
5. Sports Collectibles
15. Novelty Ice Cream
Ice cream and non-dairy frozen desserts
were worth $25.1 billion globally in 2013
Market continues to fragment
1.53 Billion gallons of ice cream were
produced in the US in 2013
Americans consume almost 22 pounds of
ice cream per year
U-Vend is now the official ice cream of
Major League Baseball
16. Automated Retail
US spending through automated retail/vending
tops $7 billion annually
There are approximately 18 million machines
globally
There are as many vending machines in Japan
as there are in the U.S.
Automated retail is replacing personnel cost
Used more in areas with higher real estate
cost, globally
Wide range of products available from food to
electronics, to cosmetics and caviar
17. Fantasy Sports
Fantasy sports players are younger, better
educated, possess higher household
incomes and more likely to have fulltime
employment:
66% Male / 34% Female
Average Age: 38.6
College Degree or more: 66%
Household income of $75,000+: 51%
Have fulltime employment: 67%
Average Annual Spending Per Fantasy
Player (age 18+): $556.00
Fantasy Sports Players that pay League
Fee: 70%
18. Sport Collectibles
The market for licensed, unsigned sports
merchandise is $12 Billion
Market is moving to the digital space
Digital card games were estimated to be
$1.3 Billion in 2013
Topps Company
• 2012 – launched Topps Bunt, an app
designed to create a digital card
marketplace
• 2015 – began experimenting in Europe
19. Digital Advertising
Digital advertising in the US is a $43 Billion
market, predominantly through Facebook and
Google
Desktop revenue in 2013 was $33 Billion
Mobile doubled from $4.4 Billion in 2012 to
$9.6 Billion in 2013
Intelligent vending machines are expected to
grow at a 49% CAGR from 2010 to 2016
Mobile phones are driving market opportunity
and innovation through:
‐ Ability to make payments
‐ Interaction through device and
automated retail POS
20. Vending Kiosk
digital touch screen
touch screen program
55” wireless digital touch screen
cloud-based
wirelessly managed
Merchant POS
digital screen
digital merchandiser program
22” wireless digital screen
cloud-based
wirelessly managed
Digital
Advertising
21. Identification of Initial Region and Markets
Identification of Sports, Consumer Attractions and Local
Interests
R&D for Products and Services
Operational Analysis by Market
Implementation and Execution
Growth Strategies
U-Vend’s Expansion Process
22. North America
Sports, Consumer Attractions and Local Interests
Top 10 Sports in the US
• Football
• Baseball
• Basketball
• Ice Hockey
• Soccer
• Golf
• Tennis
• Pro Wrestling
• Motor Sports
• Martial Arts
Top 10 Sports in Canada
• Ice Hockey
• Basketball
• Soccer
• Football
• Lacrosse
• Baseball
• Cricket
• Curling
• Tennis
• Golf
Ice Cream Stats
• US Market considered mature
• Take home is 75% of market
• 62% of children 6-12 years old consume
ice cream
• 58% of adults over 75 are regular
consumers
• Average ice cream consumer eats 1.6
times per week
• Vending machines that sell ice cream
contribute $886 Million to the industry
• The United States exports 60,000 metric
tons of ice cream every year to Canada,
Mexico, and the Caribbean.
• 79.3% of ice cream consumers cited
premium ice cream as their most
favorite product.
• Only 16% of the ice cream that is sold in
the United States is marketed nationally.
23. From Store,
to Fantasy and
Social Media
and Stadium,
U-Vend is in part a multi-media company built
upon consumer products, through distribution,
automated retail and novelty ice cream
consumables.
24. Sales Cycle
Purchase
Customer buys
through vending, C-
Store, Stadium sale,
etc.
Collectible
Collect the bat for
your favorite team
Register
Sign in to the U-vend
App or website and
register your sports
collectible
Share
Share on Social
Media, or share
Collectibles with
others
Repeat
Year round sales
cycle, enormous
opportunity for
repeat sales
25. Benefits to Interactive Product
The Premium Ice Cream Product is a delivery system that leads to multiple additional sales opportunities
R&D
Increased consumer
engagement will reduce
uncertainty as U-Vend looks
to expand and built upon
product/service offerings
Customer “Stickiness”
Competition creation will lead
to increased potential of
repeat sales.
Demographics
App and website participation
provides U-vend with detailed
customer info
Psychographics
Deeper information than
demographics, tells us about
client interests, values,
opinions, lifestyles, etc.
Marketing Data
3rd party marketing firms regularly
purchase consumer data from
consumer product companies
26. 2016 Nine-Month Period End September 30, 2016 Gross Revenue increased 74.5% & Gross Profit increased 239% as
compared to Nine-Month Period Ended September 30, 2015.
Increased points of sale to 145 throughout Chicago, Southern California & Las Vegas
Financial Summary As of November 2016
0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
400,000
450,000
1Q
2015
2Q
2015
3Q
2015
4Q
2015
1Q
2016
2Q
2016
3Q
2016
Total Revenue
Total Revenue
0
50,000
100,000
150,000
200,000
250,000
1Q
2015
2Q
2015
3Q
2015
4Q
2015
1Q
2016
2Q
2016
3Q
2016
Gross Operating Profit
Gross Operating Profit
27. 1080 N. Batavia St. Unit A
Orange, CA 92867
(8 8 8 ) 5 5 U - V E N D
w w w . u - v e n d . c o m
i n f o @ u - v e n d . c o m
THANK YOU!